128 related articles for article (PubMed ID: 12768389)
1. Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels.
Akdogan M; Senturk H; Mert A; Tabak F; Ozbay G
J Gastroenterol; 2003; 38(5):465-70. PubMed ID: 12768389
[TBL] [Abstract][Full Text] [Related]
2. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
3. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
Nair S; Perrillo RP
Hepatology; 2001 Nov; 34(5):1021-6. PubMed ID: 11679974
[TBL] [Abstract][Full Text] [Related]
4. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
5. [Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1264-6, 1270. PubMed ID: 17715044
[TBL] [Abstract][Full Text] [Related]
6. Multicenter retrospective study of response to interferon in chronic hepatitis B.
Martín-Vivaldi R; Nogueras F; Vignote ML; Salmerón J; Aguilar J; Romero M; Andrade R; De la Mata M; Moreno JM; Pérez J; García G; López de Hierro M; Gómez F; Palacios A; Otero S; Suárez E; Poyatos A; Quintero D
Rev Esp Enferm Dig; 2000 Sep; 92(9):561-72. PubMed ID: 11138238
[TBL] [Abstract][Full Text] [Related]
7. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
Besirbellioglu B; Gul C; Gorenek L; Eyigun CP; Hacibektasoglu A; Van Thiel DH
Hepatogastroenterology; 1999; 46(25):387-90. PubMed ID: 10228827
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Shindo M; Hamada K; Nishioji K; Muramatsu A; Oda Y; Okuno T
J Gastroenterol; 2004; 39(3):260-7. PubMed ID: 15065004
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
[TBL] [Abstract][Full Text] [Related]
14. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
Sarin SK; Kumar M; Hissar S; Sharma BC
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
[TBL] [Abstract][Full Text] [Related]
15. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
[TBL] [Abstract][Full Text] [Related]
19. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
Akhan SC; Yulugkural Z; Vahaboglu H
Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.
Wang CC; Liu CJ; Lai MY; Kao JH; Chen DS
Liver Int; 2007 Mar; 27(2):235-9. PubMed ID: 17311619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
